5 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Hemangioma: new trials by email Literature Review of Hemangioma trials Research Report on Hemangioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile Hemangioma Abrupt Discontinuation of Propranolol, Gradual Tapering of Propranolol - Infantile Hemangioma (IH) | Phase 4 | Not yet recruiting | West China Hospital | 110 | 2026-07-01 | 2026-06-24 |
| Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas Propranolol three times a day, Propranolol twice a day, Timolol - Infantile Hemangioma | Phase 4 | Terminated | The University of Texas Health Science Center, Houston | 52 | 2022-06-23 | 2026-03-13 |
| Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma Sirolimus - Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome | Phase 4 | Completed | Children's Hospital of Fudan University | 30 | 2020-07-01 | 2023-09-26 |
| A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology Haemoblock, Placebo - Vascular Diseases, Vascular Malformation | Phase 4 | Completed | Center for Vascular Pathology, Moscow | 200 | 2020-01-01 | 2021-11-04 |
| Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma oral propranolol, Oral Captopril, intralesional propranolol injection - Infantile Hemangioma | Phase 4 | Unknown | Ain Shams University | 100 | 2019-10-01 | 2020-02-28 |
| 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. Ga68-DOTATATE-PET/MRI - CNS Tumors, Meningioma | Phase 4 | Recruiting | Weill Medical College of Cornell University | 200 | 2019-09-04 | 2026-10-30 |
| Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2) - Hemangioma, Kaposiform Hemangioendothelioma | Phase 4 | Completed | Children's Hospital of Fudan University | 92 | 2019-05-01 | 2023-01-30 |
| A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures Lipiodol Ultra Fluid with surgical glues - Congenital Hemangioma, Hemangioendothelioma | Phase 4 | Completed | Guerbet | 132 | 2017-11-29 | 2025-10-10 |
| The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma Prednisolone, Propranolol - Hemangioma | Phase 4 | Completed | Seoul National University Hospital | 34 | 2013-06-01 | 2018-12-19 |
Hemangioma, Capillary (3) · Kaposiform Hemangioendothelioma (2) · Kasabach-Merritt Syndrome (2) · Arteriovenous Malformations (1) · Capillary Malformation-Arteriovenous Malformation (1) · Capillary Malformations, Congenital, 1 (1) · Central Nervous System Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Hemangioblastoma (1) · Hemangioendothelioma (1) · Hemangiosarcoma (1) · Medulloblastoma (1) · Meningioma (1) · Paraganglioma (1)
Neoplasms (9) · Neoplasms by Histologic Type (9) · Neoplasms, Vascular Tissue (9) · Blood Platelet Disorders (2) · Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Thrombocytopenia (2)
Propranolol (2) · Sirolimus (2) · Timolol (2) · Adrenergic beta-Antagonists (1) · Captopril (1) · Ophthalmic Solutions (1) · Prednisolone (1) · Steroids (1)
Children's Hospital of Fudan University (2) · Ain Shams University (1) · Center for Vascular Pathology, Moscow (1) · Guerbet (1) · Seoul National University Hospital (1) · The University of Texas Health Science Center, Houston (1) · Weill Medical College of Cornell University (1) · West China Hospital (1)
China (3) · United States (2) · Egypt (1) · India (1) · Russia (1) · South Korea (1)
Kai Li, MD, PhD (2) · Alexander Plotkin, PhD (1) · Dmitry V Romanov, MD (1) · Ekaterina M Listovskaya, BSc (1) · Jana Ivanidze, MD/Ph.D (1) · Jing Hao, MD (1) · Kyung-Duk Park, MD, Ph D (1) · Matthew R Greives, MD (1) · Rana Atta, BSc (1) · Tae Hyun Choi, MD, Ph D (1)